Despite increased VEGF expression, studies suggest that it is ineffective in promoting angiogenesis in AD [201], as Aβ toxicity interferes with VEGF binding to its receptor, VEGFR-2, on endothelial cells, thereby interfering with its pro-angiogenic role. Here, VEGFA is linked to Alzheimer disease.